Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $75.44.
Several equities analysts have weighed in on the stock. Barclays dropped their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Royal Bank of Canada lowered their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, StockNews.com raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, December 19th.
Read Our Latest Research Report on Acadia Healthcare
Institutional Inflows and Outflows
Acadia Healthcare Trading Up 2.8 %
Shares of Acadia Healthcare stock opened at $39.65 on Friday. The company has a 50-day moving average of $41.63 and a two-hundred day moving average of $59.42. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $3.68 billion, a PE ratio of 13.00, a price-to-earnings-growth ratio of 1.77 and a beta of 1.30.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $0.91 EPS. On average, research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- Stock Dividend Cuts Happen Are You Ready?
- 3 Stocks Helping to Bring AI to Healthcare
- What Are Dividend Achievers? An Introduction
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.